Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Clinics in Laboratory Medicine|July 10, 2003
Human chorionic gonadotropin testing for early pregnancy viability and complicationsSuzy Davies, Francis Byrn, Laurence A ColeJournal of Visualized Experiments : Jove|March 17, 2025
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental OutcomesSuzy Davies, Zarena M Dominguez, Jessie R MaxwellJournal of Visualized Experiments : Jove|June 22, 2026
Diverse Methodologies Used for Preclinical Research into Prenatal Cannabis ExposureSuzy Davies, Zarena M Dominguez, Jessie R MaxwellGynecologic Oncology|November 18, 2005
Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cellsSuzy Davies, Donghai Dai, Gavin Pickett, et al.Gynecologic Oncology|May 11, 2007
Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancerLina Albitar, Mark B Carter, Suzy Davies, et al.Journal of the Society for Gynecologic Investigation|October 2, 2004
Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cellsSuzy Davies, Donghai Dai, Douglas M Wolf, et al.Alcohol (Fayetteville, N.Y.)|May 24, 2023
Impact of two different rodent diets on maternal ethanol consumption, serum ethanol concentration and pregnancy outcome measuresSuzy Davies, Danika E Nelson, Sumi Shrestha, et al.Gynecologic Oncology|August 7, 2004
Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2Suzy Davies, Donghai Dai, Irv Feldman, et al.Gynecologic Oncology|May 11, 2007
Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cellsLina Albitar, Gavin Pickett, Marilee Morgan, et al.Alcohol (Fayetteville, N.Y.)|May 5, 2024
The histamine H3 receptor inverse agonist SAR-152954 reverses deficits in long-term potentiation associated with moderate prenatal alcohol exposureMonica Goncalves-Garcia, Suzy Davies, Daniel D Savage, et al.Pageof 5